[Pharmacological pain management in cancer patients]. / Medikamentöse Schmerztherapie bei Patienten mit Tumorerkrankungen.
Urologie
; 63(5): 497-506, 2024 May.
Article
en De
| MEDLINE
| ID: mdl-38597946
ABSTRACT
Pharmacological pain therapy in cancer patients is based on guideline recommendations, which, however, do not fully coincide in all aspects due to varying weighting of evidence. The present article discusses current issues including the decreasing significance of the World Health Organization (WHO) analgesic ladder, with its distinction between step 2 and 3 being increasingly questioned. Risks of nonopioid analgesics such as paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs), particularly in older populations, are discussed. Paracetamol may potentially reduce the effectiveness of immunotherapies. Aspects of administering analgesics via a feeding tube are considered. Recommendations for the treatment of episodic pain, transitioning between different opioids, and some relevant interactions are also discussed.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Manejo del Dolor
/
Dolor en Cáncer
Límite:
Humans
Idioma:
De
Revista:
Urologie
Año:
2024
Tipo del documento:
Article